SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-070677
Filing Date
2022-03-09
Accepted
2022-03-09 16:50:06
Documents
17
Period of Report
2022-03-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d302374d8k.htm   iXBRL 8-K 29846
2 EX-99.1 d302374dex991.htm EX-99.1 5935
7 GRAPHIC g302374page1.jpg GRAPHIC 3472
8 GRAPHIC g302374page1c.jpg GRAPHIC 6715
9 GRAPHIC g302374pageb.jpg GRAPHIC 2660
  Complete submission text file 0001193125-22-070677.txt   211602

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20220309.xsd EX-101.SCH 3941
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20220309_def.xml EX-101.DEF 13311
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20220309_lab.xml EX-101.LAB 21932
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20220309_pre.xml EX-101.PRE 14208
11 EXTRACTED XBRL INSTANCE DOCUMENT d302374d8k_htm.xml XML 5630
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 22726023
SIC: 2836 Biological Products, (No Diagnostic Substances)